Home › Gastrointestinal Cancers › NCT01750619
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients age \>18 years that have been referred for endoscopic treatment of GI lesions. Exclusion Criteria: * Patients for whom endoscopic treatment was not performed.
About the study
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
Sponsor: California Pacific Medical Center Research Institute · Participants: 8,000 · Started: 2011-07
Contact the study team
- Jona C Bernabe · Phone: 415-600-1151
- Hayden Sampson · Phone: 415-600-1151
Official record on ClinicalTrials.gov — NCT01750619
Locations in the U.S.
| California | Interventional Endoscopy Services, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.